Recent analysis of 489 high-grade serous ovarian cancers by the Cancer Genome Atlas consortium indicates that FOXM1 overexpression may be a key, early event driving the growth of epithelial ovarian cancers, especially those with serous pathophysiology. The gene discussed is FOXM1; the disease is ovarian serous adenocarcinoma.